Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT)
Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
The major purpose of this research study is to better understand how therapy works on
different patients. This study is being offered to patients with a diagnosis of advanced or
metastatic breast cancer who have failed anthracycline based therapy.
The investigators want to see the response of breast cancer cell when treated with
Chloroquine used in combination with chemotherapy. Chemotherapy is an anti-cancer drug that
is given through your vein. The chemotherapy used in this study is either Taxane (Paclitaxel)
or Taxane-like drugs (Abraxane, Ixabepilone or Docetaxel).
Phase:
Phase 2
Details
Lead Sponsor:
Jenny C. Chang, MD
Collaborators:
The Methodist Hospital Research Institute The Methodist Hospital System